ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698276 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698276; 2) Community: the network communities that were significantly associated with the response to NSC 698276; 3) Molecule: the relationships between components within communities and NSC 698276; 4) MDR: the compounds that were significantly associated with the NSC 698276.

NSC Compound Enrichment Correlation
NSC 708822 Null 0.0467178916101838 0.047384477
NSC 716263 Null 0.0467178916101838 -0.25803245
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.0467178916101838 -0.20966042
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0467178916101838 -0.29249259
NSC 736200 6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline 0.0467178916101838 -0.18770515
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.0467178916101838 0.073212843
NSC 753190 3,5-dichloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide 0.0467178916101838 0.15254138
NSC 94600 Camptothecin 0.0467178916101838 -0.056360803
NSC 3060 Arsenenous acid, potassium salt (9CI) 0.0467178916101842 0.17499109
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0467178916101842 0.084592211
Total:51  Current:42    [First] [Prev] [Next] [Last]